4.5 Article

Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pediatrics

SARS-CoV-2 in pediatric cancer: a systematic review

Sandy Schlage et al.

Summary: A comprehensive overview of pediatric cancer patients with SARS-CoV-2 infections found that most patients have mild symptoms, but the mortality rate is higher compared to hospitalized children without comorbidities. Some cases showed no severe COVID-19 complications despite continuing chemotherapy.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

Article Immunology

Age-Specific Changes in Virulence Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern

David N. Fisman et al.

Summary: The study found that the variants of concern for SARS-CoV-2 may increase the relative virulence of infection in all age groups, although estimates in younger individuals may be imprecise due to low absolute numbers of outcomes. Variants with the N501Y mutation as well as the Delta variant both increase the severity of illness in both younger and older age groups.

CLINICAL INFECTIOUS DISEASES (2022)

Letter Oncology

Autoimmune hemolytic anemia in children with COVID-19

Daniele Zama et al.

PEDIATRIC BLOOD & CANCER (2022)

Article Medicine, General & Internal

Consensus on COVID-19 Vaccination in Pediatric Oncohematological Patients, on Behalf of Infectious Working Group of Italian Association of Pediatric Hematology Oncology

Simone Cesaro et al.

Summary: This consensus document aims to support the Italian pediatric hematological oncological centers in scientifically correct communication with families and patients, and to promote vaccination for pediatric oncohematological patients. The document highlights the importance of vaccination in preventing COVID-19 and enabling regular treatments for children and adolescents affected by hematological and oncological diseases. All statements were approved.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Immunology

A Pediatric Infectious Disease Perspective on COVID-19

Ellen R. Wald et al.

Summary: This review discusses the clinical and epidemiologic characteristics of COVID-19 in children and neonates, highlighting comparisons with other respiratory viruses. Despite most infections in children being mild, there are still unanswered questions that could impact disease in adults.

CLINICAL INFECTIOUS DISEASES (2021)

Letter Oncology

Children with cancer during COVID-19 pandemic: Early experience in Mexico

Enrique Lopez-Aguilar et al.

PEDIATRIC BLOOD & CANCER (2021)

Article

The Care of Children With Cancer During the COVID-19 Pandemic

Daniel C. Moreira et al.

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting (2021)

Article Oncology

Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project

Gerard C. Millen et al.

Summary: This study aimed to provide evidence on the incidence and outcomes of SARS-CoV-2 in children with cancer attending hospitals in the UK. The study found that children with cancer appear to have similar risk of severe SARS-CoV-2 infection compared to the general pediatric population, with an estimated incidence of 3% in this group. This supports the continued delivery of standard treatment for children with cancer during the pandemic.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients

Gabrielle M. Haeusler et al.

Summary: Although most children with cancer had asymptomatic or mild COVID-19, 13% of patients had severe cases and 3% died. Comorbidity, coinfection, and severe neutropenia may increase the risk of severe disease.

EUROPEAN JOURNAL OF CANCER (2021)

Article Oncology

Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study

Sheena Mukkada et al.

Summary: The study found that around one fifth of children and adolescents with cancer infected with SARS-CoV-2 developed severe or critical illness, with a higher death rate than in the general pediatric population. Factors associated with treatment modification were different from those associated with disease severity, highlighting the need to raise global awareness of the high risk of severe COVID-19 illness in children and adolescents with cancer. These findings could inform clinical guidelines and improve care practices for this vulnerable population.

LANCET ONCOLOGY (2021)

Review Environmental Sciences

Epidemiology and diagnosis, environmental resources quality and socio-economic perspectives for COVID-19 pandemic

Surindra Suthar et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 has had significant impacts on public health, environment, and socio-economic factors globally. Research shows a decrease in air pollutants with the pandemic, but high pollution cities experienced higher mortality rates in COVID-19 affected areas. Additionally, the use of health safety equipment and work-from-home policies have affected solid and hazardous waste management services.

JOURNAL OF ENVIRONMENTAL MANAGEMENT (2021)

Article Multidisciplinary Sciences

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

Rishi R. Goel et al.

Summary: This study found that immune memory to SARS-CoV-2 and its variants remains robust for at least 6 months after mRNA vaccination, with antibodies declining but still detectable in most individuals. mRNA vaccines also induced functional memory B cells and antigen-specific T cells, with recall responses primarily increasing antibody levels in individuals with preexisting immunity.

SCIENCE (2021)

Article Hematology

Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C

Hilary Whitworth et al.

Summary: This study found that age >= 12 years, cancer, presence of a central venous catheter, and MIS-C were significantly associated with thrombosis in children hospitalized with COVID-19 or MIS-C. It is notable that the majority of thrombotic events occurred in patients aged 12 years and older, and nearly one-third of patients experienced thrombosis despite receiving thromboprophylaxis.
Review Oncology

Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review

Jagdish Prasad Meena et al.

Summary: The impact of COVID-19 on pediatric oncology patients is more severe in terms of severity, morbidity, and mortality compared to the general pediatric population, with a higher percentage of severe cases.

PEDIATRIC BLOOD & CANCER (2021)

Review Genetics & Heredity

The biological and clinical significance of emerging SARS-CoV-2 variants

Kaiming Tao et al.

Summary: The emergence of multiple SARS-CoV-2 variants has significant impacts on the epidemiological and clinical aspects of the COVID-19 pandemic, including increased virus transmission rates, heightened risk of reinfection, and reduced effectiveness of neutralizing antibodies and vaccines. These variants have introduced new challenges to COVID-19 research, necessitating additional avenues of laboratory, epidemiological, and clinical studies.

NATURE REVIEWS GENETICS (2021)

Article Medicine, General & Internal

Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes

Mary Beth F. Son et al.

Summary: Initial treatment with IVIG plus glucocorticoids was associated with a lower risk of cardiovascular dysfunction compared to IVIG alone in children with MIS-C.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Immunology

SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review

Nisha S. Mehta et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer et al.

LANCET (2020)

Letter Oncology

COVID-19 in Children With Cancer in New York City

Farid Boulad et al.

JAMA ONCOLOGY (2020)

Letter Oncology

COVID-19 infection in children and adolescents with cancer in Madrid

Teresa de Rojas et al.

PEDIATRIC BLOOD & CANCER (2020)

Article Pediatrics

Epidemiology of COVID-19 Among Children in China

Yuanyuan Dong et al.

PEDIATRICS (2020)

Article Medicine, Research & Experimental

Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS CoV-2

Caroline Diorio et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Oncology

Hematological manifestations of SARS-CoV-2 in children

Chrysoula Kosmeri et al.

PEDIATRIC BLOOD & CANCER (2020)

Article Hematology

COVID-19 in Children and Adolescents With Cancer From a Single Center in Mexico City

Miguel Á. Palomo-Collí et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2020)

Article Hematology

COVID-19 in Children With Cancer

Fatma S.E. Ebeid et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2020)